Skip to Content
PR Newswire

Cut Red Tape 4 Heroes receives record donation from WellBefore of 1 million items of PPE, retail value $1 million, New free PPE campaign starts with Bellevue Hospital Workers April 26

Cut Red Tape 4 Heroes receives record donation from WellBefore of 1 million items of PPE, retail value $1 million, New free PPE campaign starts with Bellevue Hospital Workers April 26

Cut Red Tape 4 Heroes receives record donation from WellBefore of 1 million items of PPE, retail value $1 million, New free PPE campaign starts with Bellevue Hospital Workers April 26

PR Newswire

NEW YORK, April 23, 2021

NEW YORK, April 23, 2021 /PRNewswire/ -- Cut Red Tape 4 Heroes, a not-for-profit initiative that has put more than 4 million items of PPE directly in the hands of 270,000 healthcare workers and others in need since the start of the pandemic, has received a record donation of 1 million items of PPE, retail value of $1 million, from WellBefore, a Texas-based medical supplies e-commerce retailer.

 

To mark Cut Red Tape 4 Heroes' one-year anniversary, Cut Red Tape 4 Heroes will give hospital workers a month's worth of PPE April 26, 2021, starting at 11:30 a.m. outside Manhattan's Bellevue Hospital. Workers will receive KN95s, surgical masks, cloth barrier masks, and hand sanitizer.

Bellevue was the first hospital Cut Red Tape 4 Heroes volunteers brought free PPE to at the start of the pandemic's PPE shortages.

Cut Red Tape 4 Heroes will distribute the WellBefore donation of KN95s, 3-ply surgical masks, and face shields in three methods: 1) events outside hospitals for hospital workers and community members; 2) PPE drive-throughs for often-neglected small/medium organizations; and 3) delivery/pick-up for public housing complexes, first responders, and others.

"Shahzil Amin and WellBefore's gift of one million pieces is extraordinary and will support the health and wellbeing of countless New Yorkers," Cut Red Tape 4 Heroes founder Rhonda Roland Shearer said. "Our frontline workers still have to buy expensive PPE for their home and personal use. We're so pleased WellBefore has enabled us to keep saying thank you with free PPE to hospital workers who continue to put their lives and mental health on the line during the pandemic."

"Giving back is a core pillar that was infused into WellBefore since its inception," said Shahzil (Shaz) Amin, WellBefore Founder/CEO. "We donate weekly to non-profits, individuals, and many other organizations in need. The impact that Rhonda has made throughout her life, especially now with Cut Red Tape 4 Heroes, is something we deeply admire and are humbled to support."

Cut Red Tape 4 Heroes's Shearer took out a nearly $1 million loan to buy PPE for healthcare workers at the beginning of the pandemic. A GoFundMe campaign, www.cutredtape4heroes.org, has raised $500,000 to pay down her debt. For more information, contact info@asrlab.org.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cut-red-tape-4-heroes-receives-record-donation-from-wellbefore-of-1-million-items-of-ppe-retail-value-1-million-new-free-ppe-campaign-starts-with-bellevue-hospital-workers-april-26-301276150.html

SOURCE Cut Red Tape 4 Heroes

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.